177 related articles for article (PubMed ID: 7542631)
1. Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.
Gupta RK; Egan W; Bryla DA; Robbins JB; Szu SC
Infect Immun; 1995 Aug; 63(8):2805-10. PubMed ID: 7542631
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls.
Konadu E; Shiloach J; Bryla DA; Robbins JB; Szu SC
Infect Immun; 1996 Jul; 64(7):2709-15. PubMed ID: 8698499
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines.
Konadu E; Robbins JB; Shiloach J; Bryla DA; Szu SC
Infect Immun; 1994 Nov; 62(11):5048-54. PubMed ID: 7927787
[TBL] [Abstract][Full Text] [Related]
4. Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate.
Fattom A; Shiloach J; Bryla D; Fitzgerald D; Pastan I; Karakawa WW; Robbins JB; Schneerson R
Infect Immun; 1992 Feb; 60(2):584-9. PubMed ID: 1730492
[TBL] [Abstract][Full Text] [Related]
5. Comparison of conjugates composed of lipopolysaccharide from Shigella flexneri type 2a detoxified by two methods and bound to tetanus toxoid.
Polotsky VY; Robbins JB; Bryla D; Schneerson R
Infect Immun; 1994 Jan; 62(1):210-4. PubMed ID: 8262629
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid.
Chu CY; Liu BK; Watson D; Szu SS; Bryla D; Shiloach J; Schneerson R; Robbins JB
Infect Immun; 1991 Dec; 59(12):4450-8. PubMed ID: 1937803
[TBL] [Abstract][Full Text] [Related]
7. Salmonella typhi O-polysaccharide--tetanus toxoid conjugated vaccine.
Saxena M; Di Fabio JL
Vaccine; 1994 Aug; 12(10):879-84. PubMed ID: 7526567
[TBL] [Abstract][Full Text] [Related]
8. Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid.
Boutonnier A; Villeneuve S; Nato F; Dassy B; Fournier JM
Infect Immun; 2001 May; 69(5):3488-93. PubMed ID: 11292781
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid.
Lagergard T; Shiloach J; Robbins JB; Schneerson R
Infect Immun; 1990 Mar; 58(3):687-94. PubMed ID: 2407652
[TBL] [Abstract][Full Text] [Related]
10. Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1,6-glucan chain.
Altman E; Chandan V; Harrison BA; Veloso-Pita R; Li J; KuoLee R; Chen W; Vérez-Bencomo V;
Vaccine; 2012 Nov; 30(50):7332-41. PubMed ID: 22534169
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linker.
Kossaczka Z; Bystricky S; Bryla DA; Shiloach J; Robbins JB; Szu SC
Infect Immun; 1997 Jun; 65(6):2088-93. PubMed ID: 9169736
[TBL] [Abstract][Full Text] [Related]
12. Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam.
Konadu EY; Lin FY; Hó VA; Thuy NT; Van Bay P; Thanh TC; Khiem HB; Trach DD; Karpas AB; Li J; Bryla DA; Robbins JB; Szu SC
Infect Immun; 2000 Mar; 68(3):1529-34. PubMed ID: 10678970
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.
Taylor DN; Trofa AC; Sadoff J; Chu C; Bryla D; Shiloach J; Cohen D; Ashkenazi S; Lerman Y; Egan W
Infect Immun; 1993 Sep; 61(9):3678-87. PubMed ID: 8359890
[TBL] [Abstract][Full Text] [Related]
14. O-polysaccharide-protein conjugates induce high levels of specific antibodies to Pseudomonas aeruginosa immunotype 3 lipopolysaccharide.
van de Wiel PA; Witvliet MH; Evenberg D; Derks HJ; Beuvery EC
Vaccine; 1987 Mar; 5(1):33-8. PubMed ID: 2437718
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the antigenic O-polysaccharide produced by Escherichia coli serotype O:70.
MacLean LL; Perry MB
Carbohydr Res; 2010 Mar; 345(5):644-8. PubMed ID: 20110088
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of tetanus toxoid conjugates of anti-idiotypes that mimic Pseudomonas aeruginosa surface polysaccharides.
Schreiber JR; Dahlhauser P
Infect Immun; 1994 Jan; 62(1):308-12. PubMed ID: 8262644
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
[TBL] [Abstract][Full Text] [Related]
18. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
[TBL] [Abstract][Full Text] [Related]
19. Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates.
Schneerson R; Robbins JB; Parke JC; Bell C; Schlesselman JJ; Sutton A; Wang Z; Schiffman G; Karpas A; Shiloach J
Infect Immun; 1986 May; 52(2):519-28. PubMed ID: 3516876
[TBL] [Abstract][Full Text] [Related]
20. Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine.
Watson DC; Robbins JB; Szu SC
Infect Immun; 1992 Nov; 60(11):4679-86. PubMed ID: 1383154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
